SCHEMBL22011118

SCHEMBL22011118

CCCCCC1=CCC(c2cc3oc4cc(OCC)c(F)c(F)c4c3c(F)c2F)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011805 0.90 SCN9A (0.32)
SCHEMBL22011123 0.88
SCHEMBL22011187 0.82 ACE2 (0.34) ACE2
SCHEMBL7648448 0.82 ACE2 (0.34) ACE2
SCHEMBL22011232 0.79 MAPT (0.32) ACE2
SCHEMBL22011128 0.79 SPHK1 (0.45) ACE2
SCHEMBL22011209 0.78 ACE2 (0.35) ACE2
SCHEMBL22011195 0.78 SCN9A (0.39) ACE2
SCHEMBL22011806 0.77 HTR1D (0.36)
SCHEMBL22011216 0.76 MAPT (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 ACE2 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.